
BLACK DIAMOND THERAPEUTICS I
BDTXNASDAQ๐ #3344 by market capEarnings Nov 5US Equity
$2.09โฒ $0.12 (+5.56%)
๐
Pre-market$2.12โฒ 1.44%Regular close ยท extended-hours price shown1hโ
24hโฒ 5.6%
7dโฒ 17.4%
14dโฒ 26.7%
30dโฒ 9.1%
1yโผ 17.1%
๐ฆMarket Cap
$120M
Small Cap
๐Revenue Growth (YoY)
โ
๐Gross Margin
โ
๐ตFCF Margin
โ
โ๏ธP/S Ratio
โ
Otter Score
55
Weak
๐
Analyst Ratings
Price
$2.09
Total
11
Raised
0
Lowered
1
Avg PT
$11.83
H / L
$20 / $8
| Institution | Action | Rating | Date |
|---|---|---|---|
BTIG | Reiterated | Buy | 2026-04-29 |
Wedbush | Reiterated | Outperform | 2026-03-17 |
Piper Sandler | Reiterated | Overweight | 2026-01-16 |
Guggenheim | Downgraded | Buy โ Neutral | 2025-12-04 |
HC Wainwright & Co. | Reiterated | Buy | 2025-08-11 |
Stifel | Reiterated | Buy | 2025-03-07 |
Berenberg | Reiterated | Buy | 2020-11-24 |
Jefferies | Reiterated | Buy | 2020-02-24 |
Cowen & Co. | Reiterated | Outperform | 2020-02-24 |
JP Morgan | Reiterated | Overweight | 2020-02-24 |
Canaccord Genuity | Reiterated | Buy | 2020-02-24 |
One row per institution, most recent rating